Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate

Completed · Phase 1/Phase 2

Conditions studied: Chronic Central Serous Chorioretinopathy

In brief

Investigation to evaluate Anecortave Acetate in the treatment of chronic central serous chorioretinopathy

Key facts

Study ID
NCT00489840
Run by
Manhattan Eye, Ear & Throat Hospital
People needed
5
Starts
2007-05-01
Last updated by the study team
2012-10-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.